69 related articles for article (PubMed ID: 1721937)
1. [The COP-BLAM III therapy of non-Hodgkin's lymphoma].
Arai N; Hara A; Umeda M; Shirai T
Rinsho Ketsueki; 1991 Nov; 32(11):1447-52. PubMed ID: 1721937
[TBL] [Abstract][Full Text] [Related]
2. Combination chemotherapy with COP-BLAM III for intermediate and high-grade non-Hodgkin's lymphoma.
Niitsu N; Umeda M
Int J Hematol; 1994 Jul; 60(1):71-8. PubMed ID: 7522616
[TBL] [Abstract][Full Text] [Related]
3. [Treatment with ACVP-16 for relapsed and refractory non-Hodgkin's lymphoma].
Niitsu N; Hara A; Umeda M; Shirai T
Rinsho Ketsueki; 1993 Jul; 34(7):829-34. PubMed ID: 7689661
[TBL] [Abstract][Full Text] [Related]
4. [The COP-BLAM therapy for malignant lymphoma].
Arai N; Hara A; Umeda M; Shirai T
Rinsho Ketsueki; 1990 Jul; 31(7):951-7. PubMed ID: 1699008
[TBL] [Abstract][Full Text] [Related]
5. 14-day variant of the bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone regimen in advanced-stage Hodgkin's lymphoma: results of a pilot study of the German Hodgkin's Lymphoma Study Group.
Sieber M; Bredenfeld H; Josting A; Reineke T; Rueffer U; Koch T; Naumann R; Boissevain F; Koch P; Worst P; Soekler M; Eich H; Müller-Hermelink HK; Franklin J; Paulus U; Wolf J; Engert A; Diehl V;
J Clin Oncol; 2003 May; 21(9):1734-9. PubMed ID: 12721249
[TBL] [Abstract][Full Text] [Related]
6. [The effects of COP-BLAM regimen with G-CSF for intermediate and high grade non-Hodgkin's lymphoma].
Niitsu N; Umeda M
Rinsho Ketsueki; 1995 Feb; 36(2):84-90. PubMed ID: 7536279
[TBL] [Abstract][Full Text] [Related]
7. The COP-BLAM programs: evolving chemotherapy concepts in large cell lymphoma.
Coleman M; Armitage JO; Gaynor M; McDermott D; Weisenburger DD; Adler K; Beshevkin M; Silver RT; Reisman AM; Pasmantier MW
Semin Hematol; 1988 Apr; 25(2 Suppl 2):23-33. PubMed ID: 2456620
[TBL] [Abstract][Full Text] [Related]
8. European experience with ifosfamide in lymphomas.
von Kalle AK; Schaadt M; Diehl V
Semin Oncol; 1989 Feb; 16(1 Suppl 3):73-7. PubMed ID: 2468184
[TBL] [Abstract][Full Text] [Related]
9. [Usefulness of THP-COPBLM therapy in elderly patients with non-Hodgkin's lymphoma].
Niitsu N; Nakayama M; Umeda M
Gan To Kagaku Ryoho; 1997 Jan; 24(1):61-6. PubMed ID: 9020947
[TBL] [Abstract][Full Text] [Related]
10. A variant of ProMACE-CytaBOM chemotherapy for non-Hodgkin's lymphoma with threefold higher drug dose size but identical cumulative dose intensity. A pilot study of the Italian lymphoma study group (GISL).
Gobbi PG; Ghirardelli ML; Avanzini P; Baldini L; Quarta G; Stelitano C; Broglia C; Loni C; Silingardi V; Ascari E
Haematologica; 2000 Mar; 85(3):263-8. PubMed ID: 10702814
[TBL] [Abstract][Full Text] [Related]
11. Effects of Mega-COMLA (cyclophosphamide, cytarabine, vincristine, and methotrexate followed by leucovorin and prednisone) plus CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) in the treatment of lymphoid neoplasms with very poor prognosis.
Hainsworth JD; Wolff SN; Stein RS; Greer JP; Cousar JB; Greco FA
Cancer Treat Rep; 1986 Aug; 70(8):953-8. PubMed ID: 3015406
[TBL] [Abstract][Full Text] [Related]
12. [Prognostic factors of follicular lymphoma treated with combination chemotherapy].
Niitsu N; Umeda M
Rinsho Ketsueki; 1997 Jun; 38(6):496-504. PubMed ID: 9248325
[TBL] [Abstract][Full Text] [Related]
13. [A comparative study of CHOP therapy and COP-BLAM therapy for non-Hodgkin's lymphoma in elderly patients].
Arai N; Hara A; Kaneko H; Umeda M; Shirai T
Nihon Ronen Igakkai Zasshi; 1991 Sep; 28(5):672-7. PubMed ID: 1721658
[TBL] [Abstract][Full Text] [Related]
14. Lomustine, etoposide, vindesine, and dexamethasone (CEVD) in Hodgkin's lymphoma refractory to cyclophosphamide, vincristine, procarbazine, and prednisone (COPP) and doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD): a multicenter trial of the German Hodgkin Study Group.
Pfreundschuh MG; Schoppe WD; Fuchs R; Pflüger KH; Loeffler M; Diehl V
Cancer Treat Rep; 1987 Dec; 71(12):1203-7. PubMed ID: 2446751
[TBL] [Abstract][Full Text] [Related]
15. COP-BLAM regimen combined with granulocyte colony-stimulating factor and high-grade non-Hodgkin's lymphoma.
Niitsu N; Umeda M
Eur J Haematol; 1995 Aug; 55(2):88-92. PubMed ID: 7543059
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of aggressive non-Hodgkin's lymphoma with the ProMACE- CytaBOM protocol].
Mihaljević B; Jancić-Nedeljkov R; Sretenović M; Milivojević G; Janković S; Petrović M
Srp Arh Celok Lek; 1998; 126(9-10):345-8. PubMed ID: 9863405
[TBL] [Abstract][Full Text] [Related]
17. VACOP-B, high-dose cyclophosphamide and high-dose therapy with peripheral blood progenitor cell rescue for aggressive non-Hodgkin's lymphoma with bone marrow involvement: a study by the non-Hodgkin's Lymphoma Co-operative Study Group.
Santini G; Coser P; Congiu AM; Salvagno L; De Souza C; Sertoli MR; Olivieri A; Chisesi T; Rubagotti A; Truini M; Contu A; Porcellini A; Zambaldi G; Nati S; Marino G; Rizzoli V
Haematologica; 2000 Feb; 85(2):160-6. PubMed ID: 10681723
[TBL] [Abstract][Full Text] [Related]
18. Granulocyte colony-stimulating factor (G-CSF) prevents dose-limiting neutropenia in lymphoma patients receiving standard dose chemotherapy.
Dotti G; Stella CC; Mangoni L; Cottafavi L; Caramatti C; Almici C; Rizzoli V
Haematologica; 1995; 80(2):142-5. PubMed ID: 7543069
[TBL] [Abstract][Full Text] [Related]
19. [Low-grade non-Hodgkin's lymphoma: intensive combined chemotherapy].
Hattori M; Motomura S; Tomita N; Taguchi J; Tanabe J; Sakai R; Fujisawa S; Fukawa H; Kanamori H; Mouri H; Maruta A; Kodama F; Okubo T
Rinsho Ketsueki; 1996 Feb; 37(2):101-8. PubMed ID: 8852026
[TBL] [Abstract][Full Text] [Related]
20. [Results of the treatment of non-Hodgkin's lymphoma with 6 cytostatic drug combination].
Kotlarek-Haus S; Wołowiec D; Kuliszkiewicz-Janus M; Frydecka I; Urbaniak-Kujda D; Kuliczkowski K
Przegl Lek; 1989; 46(8):636-40. PubMed ID: 2480621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
